Trials / Completed
CompletedNCT02569892
Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled study of non-damaging photothermal macular grid laser versus sham laser therapy in patients with dry age-related macular degeneration (AMD) and large high-risk drusen. The goal of the study is to determine if this treatment will reduce macular drusen volume and also whether this might improve visual acuity or reduce the risk of conversion to advanced age-related macular degeneration defined as development of choroidal neovascularization or geographic atrophy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pascal Retinal Laser Photocoagulator | Sub-threshold macular laser treatment with Pascal laser Endpoint Management System |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2020-02-01
- Completion
- 2021-01-25
- First posted
- 2015-10-07
- Last updated
- 2021-10-28
- Results posted
- 2021-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02569892. Inclusion in this directory is not an endorsement.